Parameters | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age (>60 vs ≤60) | 1.567 (0.850–2.891) | 0.150 | ||
Sex (male vs female) | 1.008 (0.550–1.848) | 0.980 | ||
B symptoms (present vs absent) | 2.302 (1.255–4.221) | 0.007 | ||
LDH (>ULN vs normal) | 4.022 (2.026–7.984) | <0.001 | ||
ECOG score (2-4 vs 0-1) | 2.785 (1.518–5.108) | 0.001 | ||
Ann Arbor Stage (III-IV vs I-II) | 1.919 (0.967–3.810) | 0.062 | ||
Extranodal disease (>1 vs ≤1) | 2.089 (1.144–3.815) | 0.017 | ||
IPI | <0.001 | <0.001 | ||
Low risk (0-1) | reference | reference | ||
Low-intermediate risk (2) | 1.146 (0.408–3.219) | 0.797 | 1.144 (0.407–3.215) | 0.798 |
High-intermediate risk (3) | 4.044 (1.763–9.276) | 0.001 | 3.516 (1.519–8.139) | 0.003 |
High risk (4-5) | 5.441 (2.324–12.739) | <0.001 | 4.722 (1.999–11.154) | <0.001 |
Subtype (GCB vs non-GCB) | 1.254 (0.795–1.979) | 0.331 | ||
FFAs (high vs normal) | 2.698 (1.385–5.258) | 0.004 | 2.075 (1.051–4.096) | 0.035 |